ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,026,000 | +325.7% | 645,400 | +885.3% | 0.07% | +407.1% |
| Q3 2018 | $241,000 | -56.5% | 65,500 | -66.6% | 0.01% | -56.2% |
| Q2 2018 | $554,000 | +48.9% | 195,900 | +95.3% | 0.03% | +33.3% |
| Q1 2018 | $372,000 | -81.6% | 100,300 | -85.7% | 0.02% | -77.8% |
| Q4 2017 | $2,018,000 | +61.6% | 701,000 | +152.0% | 0.11% | +61.2% |
| Q3 2017 | $1,249,000 | +39.1% | 278,200 | +42.1% | 0.07% | +21.8% |
| Q2 2017 | $898,000 | -70.0% | 195,800 | -72.4% | 0.06% | -70.9% |
| Q1 2017 | $2,989,000 | -26.0% | 710,100 | -27.4% | 0.19% | -43.1% |
| Q4 2016 | $4,041,000 | +480.6% | 978,600 | +1037.9% | 0.33% | +492.9% |
| Q3 2016 | $696,000 | -52.9% | 86,000 | -54.6% | 0.06% | -59.4% |
| Q2 2016 | $1,477,000 | +65.8% | 189,400 | +64.0% | 0.14% | +53.3% |
| Q1 2016 | $891,000 | – | 115,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |